Jeffrey S. Finnin
Net Worth
Last updated:
What is Jeffrey S. Finnin net worth?
The estimated net worth of Mr. Jeffrey S. Finnin is at least $46,425,656 as of 1 Nov 2021. He owns shares worth $18,275,582 as insider, has earned $17,956,674 from insider trading and has received compensation worth at least $10,193,400 in Cencora.
What is the salary of Jeffrey S. Finnin?
Mr. Jeffrey S. Finnin salary is $849,450 per year as Chief Financial Officer & Treasurer in Cencora.
How old is Jeffrey S. Finnin?
Mr. Jeffrey S. Finnin is 62 years old, born in 1963.
What stocks does Jeffrey S. Finnin currently own?
As insider, Mr. Jeffrey S. Finnin owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cencora (COR) | Chief Financial Officer & Treasurer | 62,374 | $293 | $18,275,582 |
What does Cencora do?
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Jeffrey S. Finnin insider trading
Cencora
Mr. Jeffrey S. Finnin has made 56 insider trades between 2013-2021, according to the Form 4 filled with the SEC. Most recently he sold 4,000 units of COR stock worth $581,112 on 1 Nov 2021.
The largest trade he's ever made was exercising 62,212 units of COR stock on 29 Jul 2015. As of 1 Nov 2021 he still owns at least 62,374 units of COR stock.
Cencora key executives
Cencora executives and other stock owners filed with the SEC:
- Mr. Brian P. Warren (55) Senior Vice President of Devel. & Product Engineering
- Mr. Derek S. McCandless (54) Senior Vice President of Legal, Gen. Counsel & Sec.
- Mr. Jeffrey S. Finnin (62) Chief Financial Officer & Treasurer
- Mr. Paul E. Szurek (64) Pres, Chief Executive Officer & Director
- Mr. Steven J. Smith (60) Chief Revenue Officer